FindTrial
Sign In

A Study on the Effect of Medication Therapy Management in Reducing Medication Discrepancies During the Hospital-to-Home Transition for Patients with Lupus Nephritis

Implementation and Demonstration of Medication Therapy Management to Reduce Medication Discrepancies During the Hospital-to-Home Transition in Patients with Lupus Nephritis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108175
Enrollment
Unknown
Registered
2025-08-26
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lupus nephritis

Interventions

Patients who receive treatment for their medications from pharmacists:None
control group:None

Sponsors

Guizhou Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with lupus nephropathy; 2. Age >=18 years; 3. Post-hospital return to home; 4. Long-term post-hospital use of at least =2 prescribed medications; 5. Patients or caregivers can cooperate to complete this study.

Exclusion criteria

Exclusion criteria: 1. Patients in the terminal stage (expected survival time < 2 months); 2. Transferred to other medical institutions (including nursing homes) after the hospital; 3. Both the patient and his/her caregiver are unable to communicate with each other verbally.

Design outcomes

Secondary

MeasureTime frame
Secondary hospitalization rate;adverse reaction rate;—

Primary

MeasureTime frame
medication bias;—

Countries

China

Contacts

Public ContactQi Chen

Guizhou Provincial People's Hospital

1938934746@qq.com+86 185 8500 5177

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026